Amlodipine Besylate With Atorvastatin CalciumCadivast
Recommended · restricted CardiovascularRestrictedNot applicable line
Fixed combination for patients with concomitant hypertension and dyslipidaemia, or concomitant angina and dyslipidaemia, meeting criteria set out in the General Statement for Lipid-Lowering Drugs.
2
Submissions
2006–06
On the record
—
ICER range
Cost-min
Cost basis
Access path
- TGA registered · Cadivast
- Jul 2006Recommended · restricted
Evidence: RCT → Single-arm
- Jul 2006Recommended · restricted
Evidence: RCT → Single-arm
- PBS listing · Restricted
RecommendedDeferredNot recommended
Cost-effectiveness
Cost-minimisation analysis; no ICER calculated by design.
The PBAC considered the choice of a cost-minimisation approach valid. PBAC · 2006
Decision context
PopulationPatients with concomitant hypertension and/or angina and dyslipidaemia who are currently receiving or are appropriate for treatment with a dihydropyridine calcium channel blocker.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Jul 2006 | Recommended · restricted | amlodipine co-administered with atorvastatin | — | RCT · Other |
| Jul 2006 | Recommended · restricted | amlodipine co-administered with atorvastatin | — | Single-arm |